January 30th, 2009
Podcast 28: A discussion with Dr. Andrea Cipriani and Prof. John Geddes about their ranking of 12 antidepressants
Podcast: Play in new window | Download
Subscribe: RSS
There are a dozen new-generation antidpressants on the market now. How to sort them out? On what basis? We talk with two authors of an intriguing meta-analysis released online in Lancet this week.
And we offer the usual roundup of news and, speaking of roundups, a working name while we come up with something better than the rather staid “Admitting Diagnosis.”
Calls, comments, and complaints to 1-617-440-4374.
Links for this podcast:
- First Watch coverage of the Lancet paper on antidepressants
- Lancet‘s abstract
- The meta-analysis design
- Haemophilus influenzae type B cases from MMWR
- Alcohol abuse review in Lancet
- Kidney donation article in NEJM
Categories: antidepressants, Audio, meta-analysis
Tags: alcohol abuse, Andrea Cipriani, antidepressants, Haemophilus influenzae type B, John Geddes, kidney donors, meta-analysis, transplantation
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Most Commented
- Podcast 256 — Anthony Fauci: Talking with patients about COVID-19 (27)
- Podcast 266: Interferon and early treatment in COVID-19 bring good outcomes (8)
- Podcast 251: Intermittent fasting (7)
- Podcast 214: Drug-drug interactions and bleeding risks with NOACs (6)
- Podcast 261: COVID-19 as a medical disaster (6)
Subscribe to Clinical Conversations via Email
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin